Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (9491)	4/1/1999 12:18:00 PM
From: Cacaito	Read Replies (2) \| Respond to of 17367

Neuprex in Chlamydia disease probable trial could be on prevention on scarring of reproductive tubes and the resultant infertility, this will be highly valuable if proven worth it beyond antibiotics. Also, in the treatment of severe salpingitis (reproductive tubes inflammation) shortening hospital stay in adolescents. They are the main ones hospitalized (social issues are important here, but they are the hospitalized ones in majority of cases). Fitz-Hugh-curtis syndrome is the inflammation of the liver capsule (membrane)and is more common in adolescents with salpingitis, is a complication that mandates hospitalization and increases hospital stay. Same for the putative effects of Chlamydia in the coronary arteries, Bpi should prove itself as help beyond what now is becoming evident with antibiotics.